Apo-Dabigatran 75 mg (Dabigatran Etexilate (Dabigatran Etexilate Mesilate) CAPSULE) 75 MG

APO-Dabigatran 75 mg capsules are an oral medication used to prevent blood clots. This anticoagulant is commonly prescribed for conditions like atrial fibrillation and after certain surgeries.

Strength

75 MG

Pack Size

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-Dabigatran 75 mg is primarily used to reduce the risk of blood clots forming in the body. It is often prescribed for individuals with atrial fibrillation, a heart rhythm disorder, to lower the chance of stroke. Additionally, it may be used after hip or knee replacement surgery to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). The active ingredient, dabigatran etexilate, works by inhibiting a specific clotting factor in the blood.

Side Effects

Common effects of APO-Dabigatran 75 mg may include minor bleeding, such as nosebleeds or bruising. Some individuals might experience stomach discomfort or heartburn. In rare cases, more serious bleeding can occur, which requires immediate medical attention. Always consult a healthcare provider if you experience unusual or severe symptoms.

Precautions & Warnings

APO-Dabigatran 75 mg should be handled with care, especially if you have a history of bleeding disorders or kidney problems. It is important to follow the prescribed dosage and avoid activities that increase the risk of injury or bleeding. Regular monitoring may be necessary, particularly for individuals with kidney issues, as the medication is primarily excreted through the kidneys.

Avoid Interactions

APO-Dabigatran 75 mg can interact with other medications, including certain anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can increase the risk of bleeding. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

APO-Dabigatran 75 mg is used to prevent blood clots in conditions like atrial fibrillation and after certain surgeries.

APO-Dabigatran 75 mg should be stored at room temperature, away from moisture and heat.

Yes, APO-Dabigatran 75 mg can cause minor bleeding, such as nosebleeds or bruising. Severe bleeding is rare but requires immediate medical attention.

APO-Dabigatran 75 mg should be used with caution in individuals with kidney problems, as it is primarily excreted through the kidneys.

APO-Dabigatran 75 mg can interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.